← Open Payments lookup

MILISSA DAVIS: Open Payments

NPI 1558992701 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,044 in 74 payments from 10 companies in 2025. Trend: 2023 $594 · 2024 $1,406 · 2025 $2,044

Food & beverage: $1,940Education: $104
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.18$614
Teva Pharmaceuticals USA, Inc.17$584
ABBVIE INC.19$184
Alkermes, Inc.5$160
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$157
Otsuka America Pharmaceutical, Inc.1$124
Axsome Therapeutics, Inc.1$120
Supernus Pharmaceuticals, Inc.2$39
Vanda Pharmaceuticals Inc.1$39
E.R. Squibb & Sons, L.L.C.1$24

Products named: INGREZZA, AUSTEDO XR, UZEDY, VRAYLAR, CAPLYTA, REXULTI, Auvelity, LYBALVI.

Industry payments across SC — which companies pay providers there.